These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2055355)

  • 1. Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium.
    Moody DE; Reddy JK; Lake BG; Popp JA; Reese DH
    Fundam Appl Toxicol; 1991 Feb; 16(2):233-48. PubMed ID: 2055355
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocarcinogenesis of peroxisome proliferators.
    Rao MS; Reddy JK
    Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
    [No Abstract]   [Full Text] [Related]  

  • 3. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferation and hepatocarcinogenesis.
    Reddy JK; Rao MS
    IARC Sci Publ; 1992; (116):225-35. PubMed ID: 1428083
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell proliferation and promotion in the hepatocarcinogenicity of peroxisome proliferating chemicals.
    Cattley RC; Marsman DS; Popp JA
    Prog Clin Biol Res; 1990; 340D():123-32. PubMed ID: 2196574
    [No Abstract]   [Full Text] [Related]  

  • 6. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
    Chevalier S; Roberts RA
    Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
    Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity of peroxisome proliferators: evaluation and mechanisms.
    Reddy JK
    Biochem Soc Trans; 1990 Feb; 18(1):92-4. PubMed ID: 2185101
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peroxisomes and peroxisome proliferators. Specific environmental poisons and therapeutic agents affecting lipid metabolism and hormone release].
    Hammer TA; Waldum HL
    Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3603-8. PubMed ID: 9820005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis.
    Lake BG
    Toxicol Lett; 1995 Dec; 82-83():673-81. PubMed ID: 8597126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.
    Peters JM; Cattley RC; Gonzalez FJ
    Carcinogenesis; 1997 Nov; 18(11):2029-33. PubMed ID: 9395198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
    Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
    Reddy JK; Rao MS
    Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens.
    Williams GM; Perrone C
    Ann N Y Acad Sci; 1996 Dec; 804():554-72. PubMed ID: 8993573
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical carcinogens without mutagenic activity: peroxisome proliferators as a prototype.
    Reddy JK; Scarpelli DG; Subbarao V; Lalwani ND
    Toxicol Pathol; 1983; 11(2):172-80. PubMed ID: 6399165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation.
    Vanden Heuvel JP
    Gen Pharmacol; 1996 Oct; 27(7):1123-9. PubMed ID: 8981056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors: finding the orphan a home.
    Green S; Wahli W
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.
    Khan SH; Sorof S
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):848-52. PubMed ID: 8302856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferators and signal transduction.
    Bronfman M; Nuñez L; Orellana A; Burzio V; Hidalgo P
    Ann N Y Acad Sci; 1996 Dec; 804():403-12. PubMed ID: 8993559
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
    Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
    Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.